2024-09-18  12:43:30 PM Chg. -0.800 Volume Bid1:09:15 PM Ask1:09:15 PM Market Capitalization Dividend Y. P/E Ratio
22.200EUR -3.48% -
Turnover: -
21.400Bid Size: 300 22.400Ask Size: 300 1.47 bill.EUR - -

Business description

Genus is a world-leading animal genetics company. It provides farmers with superior genetics that enable them to more efficiently produce higher-quality animal protein, in the form of meat and milk. Genus is the market leader in porcine, dairy and beef genetics and is uniquely positioned as a global player, with a dedicated, multi-species research and development (‘R&D’) function and an international distribution network.
 

Management board & Supervisory board

CEO
Jorgen Kokke
Management board
Alison Henriksen, Dan Hartley, Jerry Thompson, Angelle Rosata, Dr Elena Rice, Dr Matt Culbertson, Jim Low
Supervisory board
Iain Ferguson, Jorgen Kokke, Alison Henriksen, Lysanne Gray, Lesley Knox, Jason Chin, Dan Hartley, Ralph Heuser
 

Company data

Name: Genus plc
Address: Matrix House, Basing View,UK-Basingstoke RG21 4DZ, Hampshire
Phone: +44-1256-347100
Fax: +44-1256-477385
E-mail: cs@genusbreeding.co.uk
Internet: www.genusplc.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 06-30
Free Float: -
IPO date: -

Investor relations

Name: Anand Date
IR phone: +44-7815-676-011
IR Fax: -
IR e-mail: anand.date@genusplc.com

Main Shareholders

Others
 
53.29%
Baillie Gifford
 
7.80%
abrdn
 
6.37%
Wellington Management
 
5.67%
BlackRock
 
5.38%
Vanguard Group
 
5.07%
Devon Equity Management
 
4.41%
Capital Group
 
4.37%
Columbia Threadneedle Investments
 
3.93%
Others
 
3.71%